Patents by Inventor Frederick A. Hicks

Frederick A. Hicks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PGD2 receptor antagonists for the treatment of inflammatory diseases
    Publication number: 20090181966
    Abstract: Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.
    Type: Application
    Filed: January 27, 2009
    Publication date: July 16, 2009
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Shomir Ghosh, Amy M. Elder, Kenneth G. Carson, Kevin T. Sprott, Sean J. Harrison, Frederick A. Hicks, Christelle C. Renou, Dominic Reynolds
  • Mesylate salt of an IKK inhibitor
    Publication number: 20090137579
    Abstract: The present invention is directed to the compound of formula (II), or a solvate thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (II), including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of a compound of formula (II), or crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.
    Type: Application
    Filed: October 22, 2008
    Publication date: May 28, 2009
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Frederick A. Hicks, Martin Ian Cooper, Marianne Langston, Adrian St. Clair Brown
  • Salts of an IKK inhibitor
    Publication number: 20090131422
    Abstract: The present invention is directed to the Tartrate, Mono-Hydrochloride, Malonate and p-Toluenesulfonate Salts of the compound of formula (I), or solvates thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the Salts, including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of the Salts, including crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.
    Type: Application
    Filed: October 22, 2008
    Publication date: May 21, 2009
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Frederick A. Hicks, Martin Ian Cooper, Adrian St Clair Brown
  • PGD2 receptor antagonists for the treatment of inflammatory diseases
    Patent number: 7504508
    Abstract: Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: March 17, 2009
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Shomir Ghosh, Amy M. Elder, Kenneth G. Carson, Kevin T. Sprott, Sean J. Harrison, Frederick A. Hicks, Christelle C. Renou, Dominic Reynolds